Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Product/R&D News
3/27/2026
CStone Reports Promising Clinical Progress for Trispecific Antibody CS...
3/26/2026
Kelun-Biotech Secures IND Approval for SKB-103 in Advanced Solid Tumor...
3/26/2026
CSPC Reports Promising Phase 1 Data for B7-H3 ADC SYS6043 in Nasophary...
3/26/2026
Novo Nordisk 'Triple-G' Diabetes Candidate Advances to Phase 3 in Chin...
3/25/2026
Innovent Eyes China Approval as IBI302 Matches Eylea in Phase 3 nAMD S...
3/25/2026
BrightGene Reports Positive Phase 1 Data for Oral GLP-1/GIP Weight-Los...
3/25/2026
Insilico Launches PandaClaw to Streamline AI-Driven Drug Discovery
3/25/2026
Innovent Reports Positive Phase 3 STAR Results for IBI302 in nAMD
3/25/2026
Hope Medicine Advances HMI-115 Into Phase III for Endometriosis
3/24/2026
LG Chem's Tigulixostat Advances to Phase 3 in China Through Innovent P...
3/24/2026
Sanofi Opens Chengdu Innovation Hub to Strengthen China Operations
3/24/2026
RemeGen's Disitamab Vedotin Approved in China for HER2-Low Breast Canc...
3/23/2026
Dizal Reports Positive Phase III WU-KONG28 Results for Sunvozertinib i...
3/23/2026
CTTQ Reports Updated Phase I Data for EGFR/c-MET Bispecific TQB2922 in...
3/23/2026
Hengrui Expands HER3 ADC SHR-A2009 Data Across Mono and Combination Se...
3/23/2026
MediLink Thera Reports Phase II Activity for YL202/BNT326 in NSCLC
3/23/2026
HUTCHMED Advances HMPL-760 Into Phase III Trial for DLBCL in China
3/20/2026
Cloudbreak Pharma Withdraws China IND for CBT-009, Refocuses Ophthalmo...
3/20/2026
Kintor Reports Positive Phase III Results for First-in-Class Hair Loss...
3/20/2026
NovaBridge Secures FDA Alignment on Accelerated Pathway for Givastomig...
3/20/2026
ELCC 2026: BioKin–Henlius Combo Shows First-Line Promise in ES-SCLC
3/17/2026
Gyre Thera Liver Fibrosis Drug Receives Priority Review in China
3/17/2026
Essight Wins FDA Clearance for First Clinical Trial of RAS G12V Bispec...
3/17/2026
Fosun Pharma Subsidiary Secures China Approval for Novel Hair-Loss The...
3/16/2026
KangaBio Advances Oncology Pipeline with FDA IND Clearance
3/16/2026
3SBio Wins U.S. FDA Clearance to Advance Metabolic Disease Antibody SS...
3/16/2026
CirCode Wins FDA Clearance to Test Circular RNA Therapy
3/13/2026
CMS Wins NMPA Approval for Desidustat Tablets to Treat Renal Anemia
3/13/2026
UniXell Secures FDA Clearance to Begin Clinical Testing of iPSC-Derive...
3/12/2026
Hansoh Launches Phase 3 Trial of B7-H3 ADC HS-20093 With PD-L1 Therapy...
Page:
1
/
22
Total number of articles:
651
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit